dpi
|
27
|
30
|
33
|
36
|
39
|
42
|
45
|
---|
Group 1
|
6/0/6b
|
6/3/6
|
6/2/6
|
6/1/6
|
6/1/6
|
6/1/6
|
6/0/6
|
Group 2
|
6/0/6
|
6/6/6
|
6/6/6
|
6/6/6
|
4/4/4
|
1/1/1
|
0/0/0
|
Group 3
|
0/0/3
|
0/0/3
|
0/0/3
|
0/0/3
|
0/0/3
|
0/0/3
|
0/0/3
|
Group 4
|
0/0/3
|
0/3/3
|
0/3/3
|
0/3/3
|
0/3/3
|
0/3/3
|
0/0/0
|
- Group 1: PCV2-infected/LPC-vaccinated/CSFV-challenged; group 2: PCV2-infected/CSFV-challenged; group 3: LPC-vaccinated/CSFV-challenged, and group 4: CSFV-challenged.
- aThe pigs were inoculated with 105.3 TCID50 of PCV2 (group 1 and 2), 1 dose of LPC vaccine (group 1 and 3), and 106.8 TCID50 of wild-type CSFV (ALD) (group 1, 2, 3, and 4) at 0, 12, and 27 dpi, respectively. The PCV2 and wild-type CSFV loads in plasma were detected by real-time PCR or reverse transcription real-time PCR, respectively.
- bNumber of PCV2-positive animals/number of wild-type CSFV-positive animals/number of surviving animals.